Market Overview

Benzinga's Top Downgrades

Share:
Related ATU
Wells Fargo Increases Valuation Range For Actuant Following Earnings Release
Actuant Q3 Results Exceed Expectations
Related XYL
Benzinga's Top Downgrades
Benzinga's Top Upgrades
Brexit kills the value trade, buy 'Stable Growers' - RBC (Seeking Alpha)

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

DateFirmActionFromTo
May 2016Topeka CapitalInitiates Coverage onHold
Apr 2016BMO CapitalInitiates Coverage onMarket Perform
Mar 2016Gabelli & CoDowngradesBuyHold

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ATU + ANTH)

View Comments and Join the Discussion!